Vagally mediated effects of glucagon‐like peptide 1: in vitro and in vivo gastric actions
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Glucagon‐like peptide‐1 (GLP‐1) is a neuropeptide released following meal ingestion that, among other effects, decreases gastric tone and motility. The central targets and mechanism of action of GLP‐1 on gastric neurocircuits have not, however, been fully investigated. A high density of GLP‐1 containing neurones and receptors are present in brainstem vagal circuits, suggesting that the gastroinhibition may be vagally mediated. We aimed to investigate: (1) the response of identified gastric‐projecting neurones of the dorsal motor nucleus of the vagus (DMV) to GLP‐1 and its analogues; (2) the effects of brainstem application of GLP‐1 on gastric tone; and (3) the vagal pathway utilized by GLP‐1 to induce gastroinhibition. We conducted our experiments using whole‐cell recordings from identified gastric‐projecting DMV neurones and microinjection in the dorsal vagal complex (DVC) of anaesthetized rats while monitoring gastric tone. Perfusion with GLP‐1 induced a concentration‐dependent excitation of a subpopulation of gastric‐projecting DMV neurones. The GLP‐1 effects were mimicked by exendin‐4 and antagonized by exendin‐9–39. In an anaesthetized rat preparation, application of exendin‐4 to the DVC decreased gastric tone in a concentration‐dependent manner. The gastroinhibitory effects of exendin‐4 were unaffected by systemic pretreatment with the pro‐motility muscarinic agonist bethanechol, but were abolished by systemic administration of the nitric oxide synthase (NOS) inhibitor NG‐nitro‐l‐arginine methyl ester (l‐NAME), or by bilateral vagotomy. Our data indicate that GLP‐1 activates selective receptors to excite DMV neurones mainly and that the gastroinhibition observed following application of GLP‐1 in the DVC is due to the activation of an inhibitory non‐adrenergic, non‐cholinergic input to the stomach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 5×
“…the level of the CNS. Centrally acting GLP-1 acts via vagally mediated pathways to induce the release of insulin, decrease food intake and delay gastric emptying, as well as playing a relevant role in interoceptive stress (Rinaman, 1999a,b; Lachey et al. 2005; Baggio & Drucker, 2007; Holst, 2007).”
BackgroundMethodInfluentialThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Interactions of Glucagon-Like Peptide-1 (GLP-1) with the Blood-Brain Barrier
Kastin, A. J., Akerstrom, V., & Pan, W. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:07 · Cited by 480
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 2×
“DMV, NTS and the area postrema) (Shimizu et al. 1987; Kanse et al. 1988; Uttenthal et al. 1992; Goke et al. 1995; Larsen et al. 1997).”
BackgroundGlucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432
Delgado-Aros, S., Kim, D.-Y., Burton, D. D., Thomforde, G. M., Stephens, D., Brinkmann, B. H., Vella, A., & Camilleri, M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2002.282.3.g424 · Cited by 235 · cited 2×
“…to modulate gastric motility and emptying as well as increasing insulin release via actions at specific GLP-1 receptors on pancreatic β cells (Thorens, 1995; Delgado-Aros et al. 2002; Mayo et al. 2003; Schirra & Goke, 2005; Beglinger & Degen, 2006; Drucker, 2006; Andrews et al. 2007; Holst, 2007).”
BackgroundSchirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gut · doi:10.1136/gut.46.5.622 · Cited by 145
Cited by
Browning, K. N., & Travagli, R. A. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130055 · Cited by 541
“…(NE) (50, 318), opioid peptides (72, 73, 402), orexin (192), oxytocin (86,229), corticotropin releasing factor (291,460,501), endocannabinoids (138, 185), neurokinins (281, 284, 292), CCK (32,83,231,549), thyrotropin-releasing hormone [TRH; (70,497)] and glucagon-like peptide 1 (71,228).”
Self-citationAdvances in the physiology of gastric emptying
Goyal, R. K., Guo, Y., & Mashimo, H. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13546 · Cited by 369
Vagal neurocircuitry and its influence on gastric motility
Travagli, R. A., & Anselmi, L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.76 · Cited by 323
Self-citationThe incretin system in healthy humans: The role of GIP and GLP-1
Holst, J. J. (2019) · Metabolism · doi:10.1016/j.metabol.2019.04.014 · Cited by 248
Preproglucagon neurons project widely to autonomic control areas in the mouse brain
Llewellyn-Smith, I. J., Reimann, F., Gribble, F. M., & Trapp, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.023 · Cited by 194
“Although electron microscopic proof is not available, it now seems highly likely that the functional GLP-1 receptors found on pancreas-projecting dorsal vagal neurons (Wan et al., 2007b, Holmes et al., 2009) receive GLP-1 from neighbouring PPG neurons.”
BackgroundLiraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight
Jelsing, J., Vrang, N., Hansen, G., Raun, K., Tang‐Christensen, M., & Bjerre Knudsen, L. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01557.x · Cited by 155
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
Madsbad, S. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12119 · Cited by 146
Mechanisms responsible for excess weight loss after bariatric surgery
Ionut, V., & Bergman, R. N. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500536 · Cited by 105
GLP‐1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
Roth, J. D., Erickson, M. R., Chen, S., & Parkes, D. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01537.x · Cited by 74
Milder, D. A., Milder, T. Y., Liang, S. S., & Kam, P. C. A. (2024) · Anaesthesia · doi:10.1111/anae.16306 · Cited by 62
Nathan, B. M., Rudser, K. D., Abuzzahab, M. J., Fox, C. K., Coombes, B. J., Bomberg, E. M., & Kelly, A. S. (2016) · Clinical Obesity · doi:10.1111/cob.12128 · Cited by 39
Chronic high fat diet impairs glucagon like peptide-1 sensitivity in vagal afferents
Al Helaili, A., Park, S. J., & Beyak, M. J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.045 · Cited by 17
Metadata
- Authors
- Holmes, G. M., Browning, K. N., Tong, M., Qualls‐Creekmore, E., & Travagli, R. A.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2009-09-29
- Volume
- 587
- Issue
- 19
- Pages
- 4749-4759
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W1582182371
- Cited by
- 92
- References
- 8
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.